Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Patients”

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT04488185
What this trial is testing

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Not applicableStudy completedNCT01401452
What this trial is testing

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 246
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090330
What this trial is testing

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 80
Large-scale testing (Phase 3)Study completedNCT03849404
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 413
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Post-approval studies (Phase 4)Study completedNCT01707043
What this trial is testing

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris

Who this might be right for
Plaque Psoriasis
Wake Forest University 20
Testing effectiveness (Phase 2)UnknownNCT06170840
What this trial is testing

QY101 Ointment in Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 160
Post-approval studies (Phase 4)Looking for participantsNCT04537689
What this trial is testing

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Singapore General Hospital 40
Large-scale testing (Phase 3)Study completedNCT06398652
What this trial is testing

Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Taizhou Mabtech Pharmaceutical Co.,Ltd 336
Post-approval studies (Phase 4)Study completedNCT02752776
What this trial is testing

Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 1,660
Not applicableLooking for participantsNCT06258668
What this trial is testing

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Bristol-Myers Squibb 505
Testing effectiveness (Phase 2)Looking for participantsNCT06592274
What this trial is testing

HB0017 in Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
Huabo Biopharm Co., Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00759161
What this trial is testing

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 35
Not applicableActive Not RecruitingNCT06488170
What this trial is testing

Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 42
Large-scale testing (Phase 3)Looking for participantsNCT07265284
What this trial is testing

Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 104
Post-approval studies (Phase 4)Study completedNCT00669214
What this trial is testing

Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp

Who this might be right for
Psoriasis
Genentech, Inc. 89
Testing effectiveness (Phase 2)Study completedNCT00823693
What this trial is testing

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Who this might be right for
Psoriasis
Revotar Biopharmaceuticals AG 107
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation